Biologically Active Peptides
Bioactive peptide
Bioactive peptides have a protective effect against oxidative damage acting as free radical scavengers and metal ion chelators against enzymatic and non‐enzymatic peroxidation of lipids and essential fatty acids. Another field of action of bioactive peptides is related to their antimicrobial and immunomodulatory effect. In addition, the effects of numerous of these peptides have been investigated by Peptide Pharma Nova team on a variety of cancer cell lines and disease models.
Showing 145–180 of 1047 results
Nombre
Catalogue
Target
Category
Subcategory
-
Peptide name
Catalogue
PPH08-0042Target
Peptide with Reversed Sequence of Amyloid ß-ProteinCategory
-
Peptide name
Catalogue
PPH08-0043Target
Peptide with Reversed Sequence of Amyloid ß-Protein (Human, 1-42)Category
-
Peptide name
Catalogue
PPH08-0044Target
Blocker for Plaque-Induced Microgliosis / Reducer for Brain InflammationCategory
-
Catalogue
PPH08-0102Target
Our undiluted antisera are suitable for immuno-histochemical use, for application to radioimmunoassay (RIA), or other non-isotopicimmunoassay systems These antisera are partially characterized by either of the following two methods: 1) (EIA) or 2) ELISACategory
-
Peptide name
Catalogue
PPH08-0119Target
Amyloidogenic Segment of Amyloid ß-ProteinCategory
-
Peptide name
Catalogue
PPH08-0121Target
Endogenous Form of Amyloid ß-Protein in Cerebrospinal FluidCategory
-
Catalogue
PPH08-0045Target
Specific Form Easily Transferrable to ß-StructureCategory
-
Catalogue
PPH08-0046Target
Peptide Deposited in the Brain of Alzheimer's Disease PatientCategory
-
Catalogue
PPH08-0103Target
Our undiluted antisera are suitable for immuno-histochemical use, for application to radioimmunoassay (RIA), or other non-isotopicimmunoassay systems These antisera are partially characterized by either of the following two methods: 1) (EIA) or 2) ELISA.Category
-
Peptide name
Catalogue
PPH08-0047Target
Major Plaque Component in Alzheimer's DiseaseCategory
-
Peptide name
Catalogue
PPH08-0048Target
Major Plaque Component in Alzheimer's DiseaseCategory
-
Peptide name
Catalogue
PPH08-0049Target
Neurotrophic / Neurodegenerative Peptide, Abeta 25-35 is the shortest amyloid fragment that forms β-sheet fibrils, while retaining toxicity, and may also induce the aggregation of tau protein and tau peptide 1/2R.Category
-
Catalogue
PPH08-0098Target
Undiluted antisera are suitable for immuno-histochemical use, for application to radioimmunoassay (RIA), or other non-isotopicimmunoassay systems These antisera are partially characterized by either of the following two methods: 1) (EIA) or 2) ELISACategory
-
Catalogue
PPH08-0100Target
Our undiluted antisera are suitable for immuno-histochemical use, for application to radioimmunoassay (RIA), or other non-isotopicimmunoassay systems These antisera are partially characterized by either of the following two methods: 1) (EIA) or 2) ELISACategory
-
Catalogue
PPH08-0104Target
Our undiluted antisera are suitable for immuno-histochemical use, for application to radioimmunoassay (RIA), or other non-isotopicimmunoassay systems These antisera are partially characterized by either of the following two methods: 1) (EIA) or 2) ELISACategory
-
Peptide name
Catalogue
PPH08-0176Target
Aß (1-40) together with Aß (1-42) are two major C-terminal variants of the Aß protein constituting the majority of Aßs. These undergo post-secretory aggregation and deposition in the Alzheimer’s disease brain.Category
-
Peptide name
Catalogue
PPH08-0173Target
Amyloid beta 1-42 (Aβ42) plays a central role in the pathogenesis of Alzheimer’s disease (AD). Recombinant Aβ42 has reproducibly been shown to have higher in vitro toxicity and aggregate significantly faster than synthetically prepared Aβ42 due to the absCategory
-
Peptide name
Catalogue
PPH08-0177Target
Control PeptideCategory
-
Peptide name
Catalogue
PPH08-0175Target
Control PeptideCategory
-
Peptide name
Catalogue
PPH08-0174Target
Beta amyloid (42-1) is the reverse of beta amyloid (1-42) and is used as a control peptide. Beta amyloid (1-42) is a member of beta amyloid-peptides, which are involved in the amyloid beta-peptide (A beta)-associated free radical oxidative stress model foCategory
-
Peptide name
Catalogue
PPH08-0143Target
For the preparation of Amyloid β-Protein (Human, 1-42) using a pH-induced acyl shift and mitigating aggregation. Ester bond between Gly25 α-carboxyl group and Ser26 β-hydroxyl groupCategory
-
Catalogue
PPH08-0171Target
Control Peptide for Amyloid β-Protein (Human, 1-40)Category
-
Catalogue
PPH08-0172Target
Control Peptide for Amyloid β-Protein (Human, 1-42)Category
-
Peptide name
Catalogue
PPH08-0141Target
Endogenous Truncated Amyloid β-ProteinCategory
-
Peptide name
Catalogue
PPH08-0050Target
Vasodilator agentCategory
-
Peptide name
Catalogue
PPH08-0051Target
Vasodilator agentCategory
-
Peptide name
Catalogue
PPH08-0110Target
Potent endogenous vasoconstrictor peptide.Category
-
Peptide name
Catalogue
PPH08-0052Target
Angiotensin I is a putative neurotransmitter.Category
-
Peptide name
Catalogue
PPH08-0053Target
Angiotensin I is a putative neurotransmitter.Category
-
Peptide name
Catalogue
PPH08-0054Target
Angiotensin II (angII) human has been used to study its effect on interleukin-1β–mediated islet inflammation and β-cell dysfunction. It has been used to determine if angII activates specific calcineurin-dependent NFAT (nuclear factor of activated T-cells)Category
-
Peptide name
Catalogue
PPH08-0055Target
Angiotensin II (angII) human has been used to study its effect on interleukin-1β–mediated islet inflammation and β-cell dysfunction. It has been used to determine if angII activates specific calcineurin-dependent NFAT (nuclear factor of activated T-cells)Category
-
Peptide name
Catalogue
PPH08-0056Target
Is a heptapeptide agonist at the angiotensin 1 (AT1) and AT2 receptors, with a 30-fold higher affinity for AT2 compared with AT1 in HEK293 cells.Category
-
Peptide name
Catalogue
PPH08-0057Target
Is a heptapeptide agonist at the angiotensin 1 (AT1) and AT2 receptors, with a 30-fold higher affinity for AT2 compared with AT1 in HEK293 cells.Category
-
Peptide name
Catalogue
PPH08-0058Target
Angiotensin IV is a less effective agonist at the angiotensin AT1 receptor.Category
-
Peptide name
Catalogue
PPH08-0059Target
Angiotensin IV is a less effective agonist at the angiotensin AT1 receptor.Category
-
Peptide name
Catalogue
PPH08-0115Target
Cardiovascular System & DiseasesCategory